SCHEMBL7927701

SCHEMBL7927701

COC(=O)c1ccc(-c2ccc3cc(OCc4ccccc4)c(C45CC6CC(CC(C6)C4)C5)cc3c2)s1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR4A2 P43354 1/20 0.45
MEN1 O00255 4/20 0.44
KMT2A Q03164 4/20 0.44
RARB P10826 4/20 0.44
RARG P13631 4/20 0.44
RARA P10276 3/20 0.44
LMNA P02545 2/20 0.44
NR1I2 O75469 1/20 0.44
PGR P06401 1/20 0.44
HSPD1 P10809 1/20 0.44
GOT1 P17174 1/20 0.44
GLRA1 P23415 1/20 0.44
BLM P54132 1/20 0.44
HSPE1 P61604 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
S1PR1 P21453 1/20 0.40
CNR2 P34972 5/20 0.39
FAAH O00519 4/20 0.39
THRB P10828 1/20 0.39
RECQL P46063 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7512464 0.93 NR4A2 (0.53) NR4A2MEN1KMT2ARARBRARG
SCHEMBL7926514 0.85 RARB (0.54) MEN1KMT2ARARBRARGRARA
SCHEMBL7929545 0.83 RARB (0.47) MEN1KMT2ARARBRARGRARA
SCHEMBL27426477 0.81 MEN1 (0.37) NR4A2MEN1KMT2ARARBRARG
SCHEMBL7518648 0.79 MEN1 (0.64) NR4A2MEN1KMT2ARARBRARG
SCHEMBL8457461 0.78 RARB (0.48) MEN1KMT2ARARBRARGRARA
SCHEMBL7517611 0.77 MEN1 (0.53) MEN1KMT2ARARBRARGRARA
SCHEMBL8460810 0.77 RARB (0.43) MEN1KMT2ARARBRARGRARA
SCHEMBL8457462 0.76 HIF1A (0.47) MEN1KMT2ARARBRARGRARA
SCHEMBL8438827 0.75 MEN1 (0.66) MEN1KMT2ARARBRARGRARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6225328-B1 FOR THERAPY OF DISORDERS OR AILMENTS RELATED TO AN OVERREGULATION OF RETINOIC ACID RECEPTORS AND/OR TO HYPERVIAMINOSIS A CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES (FR) 2001-05-01 US disclosed
US-5952382-A INHIBITING THE BIOLOGICAL EFFECTS OF AN OVERREGULATION OF RETINOID ACID RECEPTORS AND/OR OF A HYPERVITAMINOSIS A; TREATING SKIN DISORDER, EYE VISION DEFECTS, SKIN AGING CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (FR) 1999-09-14 US disclosed
US-5723499-A Polycyclic aromatic compounds and pharmaceutical/cosmetic compositions comprised thereof C.I.R.D. GALDERMA (FR) 1998-03-03 US disclosed